Transfusion Medicine

Papers
(The TQCC of Transfusion Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Author Index18
Issue Information16
Drivers of blood use in paediatric trauma: A retrospective cohort study16
14
Iron deficiency in whole blood donors in a resource‐poor setting: A cross‐sectional study in Uganda13
Role of disruptions in O RhD negative donations in Colombia on increasing maternal mortality ratio from haemorrhage12
2021: That was the year that was12
The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major11
Reflection from managing blood supply during social unrest10
Severe acute haemolytic transfusion reaction secondary to a plasma incompatible group B platelet transfusion10
Recruiting racialised youth to a stem cell registry in Canada10
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis9
Hemolysis during therapeutic plasma exchange: A rare phenomena9
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach9
Cold agglutinin syndrome in a patient with anaemia and beta‐thalassemia trait8
SHOT UK Collaborative Reviewing and Reforming IT Processes in Transfusion (SCRIPT) survey: Laboratory information management systems: Are we ready for digital transformation?7
Plenary session III7
Real world reduction in red cell transfusion with restrictive transfusion threshold in haematology inpatients6
CEBPA and GATA2 mutation and a transient blood group discrepancy in a patient with acute myeloid leukaemia6
Issue Information6
A safety comparison of heparin and argatroban anticoagulation in veno‐venous extracorporeal membrane oxygenation with a focus on bleeding6
Rhnull phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene6
6
Placebo and nocebo effects in transfusion medicine6
A possible dose‐response equation: Viral load after plasma infusion in COVID‐19 patients and anti‐SARS‐CoV‐2 antibody titers in convalescent plasma6
Reducing blood component wastage through targeted interventions: A four‐year retrospective study at a Saudi tertiary hospital5
Pitfalls of reasoning in hospital‐based transfusion medicine5
Paroxysmal cold hemoglobinuria: A diagnostic dilemma in a paediatric patient5
Motivations for blood donation by HIV‐positive individuals on antiretrovirals in South Africa: A qualitative study5
Plenary II5
Preventative plasmapheresis in a diabetic pregnant patient with hypertriglyceridemia and distal pancreatectomy5
Serological and molecular characterisation of the most prevalent weak D variants in Croatian population5
Lipidomic changes occurring in platelets during extended cold storage5
Issue Information5
Author index5
D−− phenotype in a South Indian family: A multicentric approach to workup and management5
Deviations in red cell blood component temperature during laboratory processing and at blood return monitored by a time–temperature indicator device4
Abstracts for the Australian and New Zealand Society of Blood Transfusion (ANZSBT) stream of the BLOOD 2022 Meeting 11th – 14th September 2022, Sydney, Australia4
Issue Information4
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia4
Identification of two novel RHD and one novel RHCE gene promoter variants in Chinese Han blood donors4
4
4
Improved detection of hepatitis C virus‐positive blood donors and determination of infection status4
Poster Presentations4
Evaluation of Dengue, Zika virus, and Chikungunya virus transmission by blood components in recipients of haematopoietic stem cell transplantation4
3
Implementation of a patient blood management programme for platelet therapy among haemato‐oncology patients—A quasi‐experimental study3
Effects of cryopreservation on gram‐positive bacteria contaminants in umbilical cord blood3
Primary or anamnestic antibody response to the D antigen (RhD)after bone grafting: Case report and implications3
Prevalence of anaemia among blood donors in eastern Morocco: The need for pre‐donation haemoglobin assessment3
Lessons learned from the CONCOR‐1 trial3
Hyperhaemolysis caused by anti‐HI antibodies in a patient with myelodysplastic syndrome following a first ever red cell transfusion3
Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia3
An accurate genetic assay to identify human neutrophil antigen 2 deficiency3
The contribution and potential of older blood donors in Asia Pacific regions3
Red blood cell transfusion in myelodysplastic syndromes: A systematic review3
Chikungunya and Mayaro infective viruses in components of blood3
It is not all anti‐policy attitudes: Viewing blood donation as a means to belong predicts blood donation among men who have sex with men3
The use of predictive modelling to determine the likelihood of donor return during the COVID‐19 pandemic3
Impact of elevated leukocyte levels on ABO blood group typing and cross‐matching3
Acute pancreatitis from a delayed haemolytic transfusion reaction3
Abstracts for the Australian and New Zealand Society of Blood Transfusion (ANZSBT) Stream of the BLOOD 2023 Meeting 5th – 8th November 2023, Melbourne, Australia2
Knowledge and attitudes of apheresis donors regarding apheresis blood donation2
Apparent changes in RhD status during pregnancy: A case study of weak D variant due to RHD*DAU‐22
SARS‐CoV‐2 infection in the blood transfusion setting2
2
Universal new blood cell elution method with extensive phenotyping2
Intravenous immunoglobulin alteration in response to adverse reactions in neurological conditions: A retrospective cohort study2
Blood loss and transfusion risk in intramedullary nailing for subtrochanteric fractures2
Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection2
Plenary session III2
Evidence cornered: Transfusion evidence summary—efficacy and safety of early administration of 4‐factor prothrombin complex concentrate in patients with trauma at risk of massive transfusio2
Fresh frozen plasma: Beyond coagulation factor content2
Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England2
2
Safe handovers: Safe patients‐why good quality structured handovers in the transfusion laboratory are important2
Issue Information2
Severe fetal anaemia due to red cell alloimmunisation in a Rhnull woman: A case report2
Systematic literature review and meta‐analysis of concordance and accuracy of pretransfusion immunohematology routine tests2
Factors affecting the efficacy of human leukocyte antigen‐selected platelet provision: A large retrospective study in the United Kingdom2
Evidence Cornered: Transfusion Evidence Summary – Platelet transfusion before CVC placement in patients with thrombocytopenia (PACER trial)2
2
Understanding hepcidin for iron management in pregnancy2
Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1b: Case report and literature review2
A review of immunoglobulin use in a district general hospital setting2
Identification of a novel RHCE*Ce (829G > A) allele associated with absence of C and e antigens expression2
Bone marrow changes in a fatal case of transfusion associated—Graft versus host disease2
What is best practice for the prevention of anti‐D alloimmunisation in D‐negative recipients receiving solid organ transplants from D‐positive donors2
Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006–20152
A rapid review of strategies to manage low iron levels in adults donating whole‐blood: A focus on donor behaviour2
Plenary session I2
Ferritin‐guided management of blood donors with a marginally low pre‐donation haemoglobin and its effect on the number of donations in the following 3 years2
BGvar: A comprehensive resource for blood group immunogenetics2
Issue Information2
Review of transfusion practice for beta thalassaemia major patients in Scotland after removal of age criteria for red cell transfusion2
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation2
Exploring the increasing need for plasma collection: Perspectives of voluntary nonremunerated donors on payment for plasma in Canada2
Apheresis procedures for the treatment of patients and for the collection of cellular therapy products: A British Society for Haematology guideline2
Reflections of a re‐engaged donor. A response to ‘on consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities’2
Issue Information2
0.14127898216248